Dedicated to your research needs.

Subscribe

Please enter subscribe form shortcode

An in vivo CRO is a third-party contract research organization that specializes in the evaluation and assessment of drugs and medical devices during the nonclinical or preclinical stages of drug product development.

In vivo CROs provide a range of services including project management, data collection, drug testing, biomaterials testing, toxicology, dose-response studies, regulation compliance, safety and efficacy evaluations, quality analysis, customization of in vivo models, and species expertise. Our job is to support you. We are Sponsor-driven and Patient-Focused.

Working with an in vivo CRO can help to reduce costs associated with drug discovery and development while ensuring that research is performed in compliance with regulatory standards. Additionally, outsourcing research activities to Anilocus allows Sponsors to focus on core competencies while utilizing the expertise of a rapidly growing in vivo CRO improving the standards of nonclinical laboratory research.

Anilocus offeres over 130+ in vivo contract research services. We conduct in vivo research for multiple disease indications, drug formulations, animal models, drug administration routes, assessing drug and device safety and efficacy every step of the way. Our services can be either GLP-compliant or non-GLP-compliant.

We can assess a wide range of drug modalities, drug formulations, and drug administration routes for pharmacokinetic and pharmacodynamic parameters, as well as efficacy. These include single and multiple-dose regimens of small and large molecules, cell-based therapies, gene-based therapies, biologics, and various drug delivery systems.

Anilocus is a preclinical contract research organization (CRO) that specializes in in vivo studies for the development of pharmaceuticals and medical devices.

Anilocus has a team of experienced scientists and technicians who have a deep understanding of drug development and have an extensive knowledge in the regulatory requirements for drug approval.

Anilocus specializes in a variety of in vivo models including rodents, canines, non-human primates, and other species. The majority of Sponsors select mice and rats for the early-stage preclinical/nonclinical studies. Our studies are conducted at two different AAALAC-accredited facilities for small and large animals.

In preclinical studies, animals are used to test the safety and efficacy of the drug in a living system. This phase typically takes anywhere from 24 hours to 24 months. The timeline is dependent on administering the drug to a variety of animals over different time periods and at different doses, observing any side effects, and measuring the drug’s effectiveness.

Outsourcing in vivo research to Anilocus can help your company save significant resources. Studies show that outsourcing in vivo research can reduce operational costs by up to 40%. This reduction comes from savings in labor costs, personnel training, materials, equipment, and overhead expenses. Additionally, outsourcing the in vivo research process can result in quicker turnaround times and improved quality of data. Think about running multiple studies in parallel where they may only be conducted sequentially when performed internally. In some cases, partnering with Anilocus provides greater access to specialized expertise and resources that would otherwise be unavailable or cost prohibitive for a pharmaceutical company. Contact us to learn more.